The global Legionella Testing Market is estimated to be valued at US$312.6 million in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Legionella testing refers to the detection and identification of Legionella bacteria in water sources. Legionella bacteria are responsible for causing Legionnaires’ disease, a severe form of pneumonia. Legionella testing helps in preventing outbreaks of this disease by ensuring the safety of water sources in various settings such as hotels, hospitals, cooling towers, and public water systems. The increasing incidence of Legionnaires’ disease outbreaks and the growing awareness regarding waterborne diseases are driving the demand for Legionella testing. Moreover, stringent government regulations and guidelines regarding water safety are further propelling the market growth.
Market Key Trends:
One key trend in the Legionella testing market is the adoption of advanced technologies for accurate and rapid testing. Traditional culture-based methods for detecting Legionella bacteria are time-consuming and often result in false-negative results. Therefore, there is a growing preference for molecular diagnostic techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS). These techniques provide quicker and more accurate results, enabling timely interventions to prevent Legionella outbreaks. Furthermore, the use of automation in Legionella testing is gaining prominence, as it improves efficiency and reduces the risk of human errors. Automated systems can perform several tests simultaneously, ensuring higher throughput and productivity in testing laboratories.
The Legionella Testing market can be segmented on the basis of type, method, end-user, and region. In terms of type, the market can be divided into laboratory testing and on-site testing. Laboratory testing dominates the market segment due to its precision and accuracy in detecting Legionella bacteria. Laboratory testing involves collecting water samples and analyzing them in a controlled environment, ensuring reliable results. On-site testing, although convenient, may lack the same level of accuracy and may be prone to errors.
Based on the method, the market can be categorized into culture method, direct fluorescent antibody test (DFA), polymerase chain reaction (PCR), serology, urinary antigen test, and others. The culture method dominates the segment as it is considered the gold standard for Legionella testing. It involves culturing the bacteria from water samples and identifying them under a microscope. PCR, on the other hand, is gaining traction due to its rapid and sensitive detection capabilities.
When it comes to end-users, the market can be segmented into hospitals and clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Hospitals and clinics account for the largest market share due to the high risk of Legionella infections in healthcare settings. Diagnostic laboratories also hold a significant market share, as they are equipped with the necessary infrastructure and expertise to carry out Legionella testing.
The global Legionella Testing market is expected to witness high growth, exhibiting a CAGR of 8.5% over the forecast period (2022-2030). This growth is primarily driven by the increasing awareness about Legionella infections and the need for preventive measures. The growing number of Legionella outbreaks in hospitals, hotels, and other public places has also contributed to the market’s growth.
From a regional perspective, North America dominates the Legionella Testing Market Growth, with the United States being a major contributor. The region’s dominance can be attributed to stringent regulations regarding Legionella control and the presence of well-established healthcare infrastructure. Europe is also a significant market for Legionella testing, mainly due to the presence of a large number of industrial facilities and the increasing adoption of Legionella testing in healthcare settings.
Key players operating in the Legionella Testing market include Eurofins Scientific, ALS Limited, Bio-Rad Laboratories, Thermo Fisher Scientific, SGS SA, NSF International, IDEXX Laboratories, Mérieux NutriSciences, Aqua Legion UK, Palintest, LuminUltra, Special Pathogens Laboratory, Romer Labs, Real Time Lab Services, and Phigenics. These companies focus on research and development activities to introduce technologically advanced testing solutions and maintain a competitive edge in the market.